MediciNova, Inc.
Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $1.33
- 52-Week Range
- $1.22 – $3.90
- Market Cap
- $65.07M
- P/E (TTM)
- —
- EPS (TTM)
- -0.21
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 1.58
- PEG Ratio
- —
- Return on Equity
- -24.80%
- Return on Assets
- -15.53%
- Gross Margin
- 42.24%
- Operating Margin
- -1232.17%
- Profit Margin
- 0.00%
- Current Ratio
- 8.75
- Debt/Equity
- 0.00
- Total Debt
- $100.54K
- Free Cash Flow
- $-6.79M
- Revenue Growth
- 12.40%
- Earnings Growth
- —
- Enterprise Value
- $38.98M
Market Snapshot
About
MediciNova is a clinical-stage biopharmaceutical company developing therapies for diseases with unmet medical needs. The company focuses on MN-166 for neurological disorders and MN-001 for fibrotic and metabolic diseases.